New Zealand markets closed

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.75-0.79 (-7.50%)
At close: 04:00PM EDT
9.87 +0.12 (+1.23%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
42,127
42,127
34,264
15,552
25,590
Selling general and administrative
25,704
25,704
19,239
14,807
11,845
Total operating expenses
67,831
67,831
53,503
30,359
37,435
Operating income or loss
-67,831
-67,831
-53,503
-30,359
-37,435
Total other income/expenses net
-15,261
-15,261
-55
-164,675
-101
Income before tax
-72,891
-72,891
-51,834
-194,912
-37,300
Income from continuing operations
-72,891
-72,891
-51,834
-194,912
-37,300
Net income
-72,891
-72,891
-51,834
-194,912
-37,300
Net income available to common shareholders
-72,891
-72,891
-51,834
-219,349
-37,300
Basic EPS
-2.12
-2.42
-3.55
-24.58
-12.20
Diluted EPS
-2.12
-2.42
-3.55
-24.58
-12.20
Basic average shares
25,677
30,123
14,621
8,925
3,059
Diluted average shares
25,677
30,123
14,621
8,925
3,059